Member Info for ShareSting

This company is going to be to small to handle what is about to happen.
That is why i believe a takeover will happen very quickly.
I would imagine a buyer is starting to accumulate a large holding now and will continue to buy up to the 30% level in preparation for a bid.
There is no need for me to ramp this share as I believe 100% in the technology.
This is the most exciting opportunity I have ever been involved in.
Good luck all.

It is difficult to tell to be honest as allot are attached to hospitals.
Dr Tim Felton is at Manchester Foundation Trust. He is coordinating both trials there. It can cover more than one hospital within the area dependent on patients.

They have 4 open observation studies and two treatment studies running.

They also look at Dara and Diagnostics.

So these chaps will be saying what if we combine SNG001 with drug xyz!

Following some digging it looks like the research and innovation centres running the Recovery trials are all also running SNG001 trials.

SNG001 via Nebuliser is allot quicker and has less side effects.

Interferon Beta 1a is stronger than Interferon Alpha.

We deliver a strong dose direct to source, injection dilutes and takes longer to work.

SNG001 will be approved as a proactive and reactive drug for use against COVID19

Email yes
Consultants being the working type not medical. Actually they will be experts in medicine, trials and regulatory application so probably a mix !

Richard confirmed Synairgen now have +50 consultants working across four key work streams.
Hospital Trial
At home Trials - see how this can be achieved
Manufacturing
Regulatory

What Synairgen has achieved in 8 weeks would take most companies 8 months.

This journey is just starting.

Www.phctrials.ox.ac.uk

This would be perfect for SNG001!

Great group in here at the moment.
Keep tweeting and reaching out to press guys and girls.
If we get onto Radio that would be amazing.

The share price is kinda of irrelevant today as it will be £10 on success. Expect allot of churn on the way up !

#prioritycovidresearch is being used to communicate trials on Twitter.

We need press attention keep tweeting both mainstream and local journalists.

Great day guys. We are starting to get the attention we deserve.

Also just on Leicester they are trialing SNG001
https://www.leicestersresearch.nhs.uk/about-us-2/covid-19-and-clinical-research/covid-19-trials/

For those that missed this
When I asked Richard if he could update Retail shareholders around via RNS or general update he said :

I am buried in work, very operational at the moment, things you'd most want me/us to be concentrating on.

He did say he would try and get a PROF to do a general update on our drug.

Some holders need to understand this is live data they are interpreting. Every patient will be reacting differently. They then need to build this data into a tech file to present to the MHRA / FDA. This is a major piece of work which would normally take years and they are trying to complete in weeks !

The placing shares have been a pain, however they have allowed the trial which will then hopefully turn. SNG001 into a globally approved drug saving lives and making some of us allot of cash.

GLA.

https://www.leicestershospitals.nhs.uk/aboutus/our-news/press-release-centre/?entryid8=76070

Research Research Research

Maq at the moment we don’t know. However Richard and the team are ultra busy in the heart of the operation so if they are seeing strong results, that will help expedite our drug application!

The majority of yesterday trades were sells, however some were buys. We are seeing placement shares changing hands. This is perfectly normal. The placement allowed the company to recruit a retain 50 odd consultants to help it run these ultra complex trials, build stock and start regulatory applications. All good.

So I asked if he could update us in marketing or RNS.
That was his response.
Sounds like they have allot of live trials and they need to collate allot of data for their drug application!

I am buried in work, very operational at the moment, things you'd most want me/us to be concentrating on.

We need some stand out media coverage.
UK press are obsessed with a vaccine when Interferon Alpha and Interferon Beta are be discussed around the world. Typical UK press.

Start tweeting more guys and girls. Spread the word !

https://www.leicestersresearch.nhs.uk/about-us-2/covid-19-and-clinical-research/covid-19-trials/

I am so surprised Matt H talked about a vaccine as though it was a given today. With 33+ different strains it is no way that easy, yet more distraction tactics !
They seem obsessed with a vaccine and not willing to consider alternatives at Government level. Very shot sited especially given the global focus on Interferon results.